Diagnostic markers for neonatal sepsis

Current Opinion in Pediatrics

Volumn 18, Issue 2, 2006, Pages 125-131

  Ng, Pak C ^a   Lam, Hugh S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell surface markers; Cytokines; Infection markers; Neonatal sepsis

Indexed keywords

ACUTE PHASE PROTEIN; CD11B ANTIGEN; CD64 ANTIGEN; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE ANTIGEN;

ANTIMICROBIAL THERAPY; BLOOD VOLUME; DISEASE MARKER; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; MEASUREMENT; NEWBORN SEPSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

ACUTE-PHASE PROTEINS; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CHEMOKINES; CYTOKINES; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; PROGNOSIS; RECEPTORS, IGG; SENSITIVITY AND SPECIFICITY; SEPSIS; SERINE PROTEINASE INHIBITORS; SERUM AMYLOID A PROTEIN;

EID: 33646535439     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000193293.87022.4c     Document Type: Review

References (45)

1. Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005; 24:635-639.
2. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292:2357-2365. A large cohort study demonstrating that neonatal sepsis amongst preterm, extremely low birth weight infants is associated with poor neurodevelopmental and growth outcomes in early childhood.
3. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285-291.
4. Ng PC, Wong HL, Lyon DJ, et al. Combined use of alcohol hand rub and gloves reduces the incidence of late onset infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004; 89:F336-F340.
5. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89:F229-F235. A comprehensive review summarizing the evolution of infection markers in neonatology over the past two decades.
6. Polin RA. The 'ins and outs' of neonatal sepsis. J Pediatr 2003; 143:3-4.
7. Ng PC. Clinical trials for evaluating diagnostic markers of infection in neonates. Biol Neonate 2005; 87:111-112. This commentary provides a useful guide to investigators evaluating new diagnostic markers of infection.
8. Ng PC, Li G, Chui KM, et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res 2004; 56:796-803. A large cohort study demonstrating that neutrophil CD64 is a very sensitive and reliable infection marker for identifying term newborns with early-onset clinical sepsis and pneumonia.
9. Ng PC, Li K, Wong RP, et al. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res 2002; 51:296-303.
10. Hodge G, Hodge S, Han P, Haslam R. Multiple leucocyte activation markers to detect neonatal infection. Clin Exp Immunol 2004; 135:125-129. A study comparing the use of different cell surface antigens as infection markers.
11. Turunen R, Andersson S, Nupponen I, et al. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005; 57:270-275. This study shows that routine measurement of CD11b density can assist in identifying infected infants 3 days before the arousal of clinical suspicion of sepsis.
12. Nupponen I, Andersson S, Jarvenpaa AL, et al. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics 2001; 108:E12.
13. Weinschenk NP, Farina A, Bianchi DW. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J Pediatr 2000; 137:345-350.
14. Nupponen I, Pesonen E, Andersson S, et al. Neutrophil activation in preterm infants who have respiratory distress syndrome. Pediatrics 2002; 110:36-41.
15. Hodge S, Hodge G, Flower R, Han P. Surface activation markers of T lymphocytes: role in the detection of infection in neonates. Clin Exp Immunol 1998; 113:33-38.
16. Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11:161-167.
17. Hallwirth U, Pomberger G, Zaknun D, et al. Monocyte phagocytosis as a reliable parameter for predicting early-onset sepsis in very low birthweight infants. Early Hum Dev 2002; 67:1-9.
18. Ng PC, Li G, Chui KM, et al. Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset neonatal infection. Biol Neonate 2005; 89:75-81. A large cohort study demonstrating that monocyte HLA-DR is not a useful marker for identifying early-onset clinical sepsis and pneumonia in newborns.
19. Hodge G, Hodge S, Markus C, et al. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? Respirology 2003; 8:157-162.
20. Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997; 77:F221-F227.
21. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88:F209-F213.
22. Schultz C, Temming P, Bucsky P, et al. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004; 135:130-136.
23. Hodge G, Hodge S, Haslam R, et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes - association with neonatal sepsis. Clin Exp Immunol 2004; 137:402-407.
24. Procianoy RS, Silveira RC. The role of sample collection timing on interleukin-6 levels in early-onset neonatal sepsis. J Pediatr (Rio J) 2004; 80:407-410.
25. D'Alquen D, Kramer BW, Seidenspinner S, et al. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res 2005; 57:263-269.
26. Franz AR, Bauer K, Schalk A, et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics 2004; 114:1-8. A multicenter, randomized, controlled study demonstrating that the use of IL-8 and CRP can safely reduce unnecessary antibiotic usage in newborns with early-onset infection.
27. Horisberger T, Harbarth S, Nadal D, et al. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial. Crit Care 2004; 8:R443-R450.
28. Orlikowsky TW, Neunhoeffer F, Goelz R, et al. Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection. Pediatr Res 2004; 56:804-809. Detergent-lysed whole blood can improve the diagnostic utilities of IL-8 compared with conventional nonlysed plasma samples.
29. van Dissel JT, van Langevelde P, Westendorp RG, et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-953.
30. Arnon S, Litmanovitz I, Regev R, et al. The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants. J Perinat Med 2004; 32:176-180.
31. Resch B, Gusenleitner W, Muller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 2003; 92:243-245.
32. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 2004; 30:1454-1460.
33. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4:620-630. A comprehensive review of the use of procalcitonin as an infection marker in children.
34. Thayyil S, Shenoy M, Hamaluba M, et al. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005; 94:155-158.
35. Arnon S, Litmanovitz I, Regev R, et al. Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants. Biol Neonate 2005; 87:105-110.
36. Lannergard A, Friman G, Ewald U, et al. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr 2005; 94:1198-1202.
37. Behrendt D, Dembinski J, Heep A, Bartmann P. Lipopolysaccharide binding protein in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004; 89:F551-F554.
38. Fries E, Kaczmarczyk A. Inter-alpha-inhibitor, hyaluronan and inflammation. Acta Biochim Pol 2003; 50:735-742.
39. Lim YP, Bendelja K, Opal SM, et al. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 2003; 188:919-926.
40. Baek YW, Brokat S, Padbury JF, et al. Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis. J Pediatr 2003; 143:11-15.
41. Resch B, Gusenleitner W, Muller W. Procalcitonin, interleukin-6, C-reactive protein and leukocyte counts in infants with bronchiolitis. Pediatr Infect Dis J 2003; 22:475-476.
42. Zakynthinos SG, Papanikolaou S, Theodoridis T, et al. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med 2004; 32:1004-1010.
43. Wittenhagen P, Kronborg G, Weis N, et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect 2004; 10:409-415.
44. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4:133-142. A comprehensive review of the role of C5a in sepsis.
45. Huber-Lang M, Sarma JV, Rittirsch D, et al. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J Immunol 2005; 174:1104-1110.